Browsing by 저자 : 강윤구
전체 결과 28건 중 1-28 번을 표시중입니다.
- 1 Article A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data 강윤구 ; 유민희 ; Do?Youn Oh ; et al 2020
- 2 Article Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial 강윤구 ; Beni B Wolf ; Cesar Serrano ; et al 2020
- 3 Article Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy 강윤구 ; CESAR SERRANO ; EVAL MEIRI ; et al 2021
- 4 Article Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial 강윤구 ; Ce´sar Serrano ; Ferry A.L.M. Eskens ; et al 2021
- 5 Article Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study 강윤구 ; Jonathan Trent ; Kate Newberry ; et al 2021
- 6 Article Clinical implications of neutrophil-to-lymphocyte ratio and MDSC kinetics in gastric cancer patients treated with ramucirumab plus paclitaxel 강윤구 ; 김형돈 ; 나영순 ; et al 2020
- 7 Article Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network 강윤구 ; A. Gronchi ; A. J. Lazar ; et al 2020
- 8 Article Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial 강윤구 ; Aiwu Ruth He ; Ana Matilla ; et al 2020
- 9 Article Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies 강윤구 ; Andrew X. Zhu ; Arndt Vogel ; et al 2020
- 10 Article Establishment of patient-derived xenografts from patients with gastrointestinal stromal tumors: analysis of clinicopathological characteristics related to engraftment success 강윤구 ; 나영순 ; 마정은 ; et al 2020
- 11 Article Gastrointestinal stromal tumours 강윤구 ; Jean-Yves Blay ; Margaret von Mehren ; et al 2021
- 12 Article Impact of L-carnitine on imatinib-related muscle cramps in patients with gastrointestinal stromal tumor 강윤구 ; 마정은 ; 백모열 ; et al 2020
- 13 Article MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma 강윤구 ; Daniel VT Catenacci ; Harry H Yoon ; et al 2021
- 14 Article Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial 강윤구 ; A Craig Lockhart ; Aleksandra Franovic ; et al 2020
- 15 Article Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial) 강윤구 ; 박숙련 ; 오호석 ; et al 2021
- 16 Article Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial) 강윤구 ; 박숙련 ; 오호석 ; et al 2021
- 17 Article Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab · Li?Tzong Chen ; · Li?Yuan Bai1 ; · Taihei Nishiyama ; et al 2021
- 18 Article Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors 강윤구 ; ASHLEY DOYLE ; CESAR SERRANO ; et al 2021
- 19 Article Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors 강윤구 ; Chia-Chi Lin ; Chia-Jui Yen ; et al 2020
- 20 Article PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer 강윤구 ; 국명철 ; 김균지 ; et al 2021
- 21 Article S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial 강윤구 ; 유민희 ; Hideo Baba ; et al 2020
- 22 Article Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF beta and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer 강윤구 ; 방영주 ; Christoph Helwig ; et al 2020
- 23 Article Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study 강윤구 ; Alejandra Negro ; Ann-Lii Cheng ; et al 2021
- 24 Article Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab 강윤구 ; Andrew X Zhu ; Arndt Vogel ; et al 2021
- 25 Article Systemic Steroid Treatment for Imatinib-Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study 강윤구 ; 김어진 ; 박숙련 ; et al 2020
- 26 Article The role of novel fusion genes in human GIST cell lines derived from imatinib-resistant GIST patients: A therapeutic potential of fusion gene 강윤구 ; 구자록 ; 나영순 ; et al 2020
- 27 Article Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2-Targeted Agent in the Real-World Setting 강윤구 ; 구동회 ; 김어진 ; et al 2021
-
28
Dissertation
다중형광염색 및 RNA 분석을 이용한 위장관 기질 종양의 포괄적 면역 프로파일링 분석: 티로신키나아제 치료의 종양 면역 미세 환경의 영향
유창훈
2018
1